Source: International review of neurobiology: cannabidiol in neurology and psychiatry. Unidades: FCFRP, FMRP
Subjects: CANABINOIDES, FARMACOCINÉTICA, BIODISPONIBILIDADE, TRANSTORNOS MENTAIS
ABNT
LIRIO, Pedro Henrique Cassario e GASPARI, Priscyla Daniely Marcato e CAMPOS, Alline Cristina de. Cannabidiol: pharmacodynamics and pharmacokinetic in the context of neuropsychiatric disorders. International review of neurobiology: cannabidiol in neurology and psychiatry. Tradução . London: Academic Press, 2024. . Disponível em: https://doi.org/10.1016/bs.irn.2024.05.001. Acesso em: 26 abr. 2026.APA
Lirio, P. H. C., Gaspari, P. D. M., & Campos, A. C. de. (2024). Cannabidiol: pharmacodynamics and pharmacokinetic in the context of neuropsychiatric disorders. In International review of neurobiology: cannabidiol in neurology and psychiatry. London: Academic Press. doi:10.1016/bs.irn.2024.05.001NLM
Lirio PHC, Gaspari PDM, Campos AC de. Cannabidiol: pharmacodynamics and pharmacokinetic in the context of neuropsychiatric disorders [Internet]. In: International review of neurobiology: cannabidiol in neurology and psychiatry. London: Academic Press; 2024. [citado 2026 abr. 26 ] Available from: https://doi.org/10.1016/bs.irn.2024.05.001Vancouver
Lirio PHC, Gaspari PDM, Campos AC de. Cannabidiol: pharmacodynamics and pharmacokinetic in the context of neuropsychiatric disorders [Internet]. In: International review of neurobiology: cannabidiol in neurology and psychiatry. London: Academic Press; 2024. [citado 2026 abr. 26 ] Available from: https://doi.org/10.1016/bs.irn.2024.05.001
